| Product Code: ETC9966889 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Genome Sequencing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Genome Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Genome Sequencing Market - Industry Life Cycle |
3.4 United States (US) Genome Sequencing Market - Porter's Five Forces |
3.5 United States (US) Genome Sequencing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Genome Sequencing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 United States (US) Genome Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United States (US) Genome Sequencing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Genome Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare |
4.2.2 Technological advancements in genome sequencing techniques |
4.2.3 Growing investments in research and development in genomics and healthcare |
4.3 Market Restraints |
4.3.1 High costs associated with genome sequencing procedures |
4.3.2 Ethical and privacy concerns related to genomic data |
4.3.3 Limited availability of skilled professionals in genomics and bioinformatics |
5 United States (US) Genome Sequencing Market Trends |
6 United States (US) Genome Sequencing Market, By Types |
6.1 United States (US) Genome Sequencing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Genome Sequencing Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Genome Sequencing Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.4 United States (US) Genome Sequencing Market Revenues & Volume, By Systems and Software, 2021- 2031F |
6.1.5 United States (US) Genome Sequencing Market Revenues & Volume, By Services, 2021- 2031F |
6.2 United States (US) Genome Sequencing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Genome Sequencing Market Revenues & Volume, By PCR, 2021- 2031F |
6.2.3 United States (US) Genome Sequencing Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.2.4 United States (US) Genome Sequencing Market Revenues & Volume, By Microarray, 2021- 2031F |
6.2.5 United States (US) Genome Sequencing Market Revenues & Volume, By Nucleic Acid Extraction, 2021- 2031F |
6.2.6 United States (US) Genome Sequencing Market Revenues & Volume, By Purification, 2021- 2031F |
6.2.7 United States (US) Genome Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Genome Sequencing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Genome Sequencing Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.3.3 United States (US) Genome Sequencing Market Revenues & Volume, By Drug Discovery and Development, 2021- 2031F |
6.3.4 United States (US) Genome Sequencing Market Revenues & Volume, By Precision Medicine, 2021- 2031F |
6.3.5 United States (US) Genome Sequencing Market Revenues & Volume, By Agriculture and Animal Research, 2021- 2031F |
6.3.6 United States (US) Genome Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Genome Sequencing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Genome Sequencing Market Revenues & Volume, By Research Centers, 2021- 2031F |
6.4.3 United States (US) Genome Sequencing Market Revenues & Volume, By Academic and Government Institutes, 2021- 2031F |
6.4.4 United States (US) Genome Sequencing Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.4.5 United States (US) Genome Sequencing Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.4.6 United States (US) Genome Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Genome Sequencing Market Import-Export Trade Statistics |
7.1 United States (US) Genome Sequencing Market Export to Major Countries |
7.2 United States (US) Genome Sequencing Market Imports from Major Countries |
8 United States (US) Genome Sequencing Market Key Performance Indicators |
8.1 Adoption rate of genome sequencing technologies in clinical settings |
8.2 Number of research publications utilizing genome sequencing data |
8.3 Rate of integration of genomic data into healthcare decision-making processes |
9 United States (US) Genome Sequencing Market - Opportunity Assessment |
9.1 United States (US) Genome Sequencing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Genome Sequencing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 United States (US) Genome Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United States (US) Genome Sequencing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Genome Sequencing Market - Competitive Landscape |
10.1 United States (US) Genome Sequencing Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Genome Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here